Se proyecta que el mercado de dispositivos de presión espiratoria positiva oscilante (OPEP) crecerá de US$ 125,66 millones en 2021 a US$ 179,34 millones en 2028; se estima que crecerá a una CAGR del 5,2% durante 2021-2028.
Los dispositivos de presión espiratoria positiva oscilatoria (PEO) se han utilizado como complemento de la fisioterapia torácica tradicional (PTC) para ayudar a eliminar las secreciones respiratorias en personas que no pueden toser, especialmente aquellas con enfermedades crónicas. El uso de dispositivos de PEO todavía es limitado en trastornos crónicos de las vías respiratorias, como fibrosis quística, bronquiectasias, bronquitis, asma bronquial y síndrome de discinesia ciliar primaria. En la enfermedad pulmonar obstructiva crónica (EPOC), los dispositivos de presión espiratoria positiva oscilatoria (PEO) ayudan a eliminar el esputo.
El crecimiento del mercado de dispositivos de presión espiratoria positiva oscilante (OPEP) se atribuye a la creciente prevalencia de la enfermedad pulmonar obstructiva crónica (EPOC) y el asma, y a los avances en las tecnologías médicas. Sin embargo, la escasa concienciación y el acceso limitado a los dispositivos OPEP obstaculizan el crecimiento del mercado.
Personalice este informe según sus necesidades
Obtendrá personalización en cualquier informe, sin cargo, incluidas partes de este informe o análisis a nivel de país, paquete de datos de Excel, así como también grandes ofertas y descuentos para empresas emergentes y universidades.
Mercado de dispositivos de presión espiratoria positiva oscilante (OPEP): perspectivas estratégicas
- Obtenga las principales tendencias clave del mercado de este informe.Esta muestra GRATUITA incluirá análisis de datos, desde tendencias del mercado hasta estimaciones y pronósticos.
Perspectivas de mercado
La creciente prevalencia de la enfermedad pulmonar obstructiva crónica (EPOC) y el asma impulsa el crecimiento del mercado
La incidencia de EPOC y fibrosis quística está aumentando en todo el mundo. Según la Organización Mundial de la Salud (OMS), las exacerbaciones de EPOC son eventos críticos. La discapacidad y la mortalidad relacionadas con la EPOC impulsan la demanda de dispositivos OPEP. Según el Centro para el Control y la Prevención de Enfermedades (CDC), aproximadamente 9 millones de adultos fueron diagnosticados con bronquitis crónica en 2018. Además, el asma se está volviendo común entre personas de todas las edades, géneros y razas. Según los CDC, aproximadamente 300 millones de personas en todo el mundo padecen asma, y se espera que se agreguen 100 millones para 2025. La prevalencia, la gravedad y la mortalidad del asma varían drásticamente en los EE. UU. El asma afecta a más de 25 millones de personas en los EE. UU., lo que equivale al 7,7 % de los adultos y al 8,4 % de los niños. Según el Informe mundial sobre asma de 2018 sobre Auckland, Nueva Zelanda, el asma ocupa el puesto 16 entre las principales causas de discapacidad y el 28 entre las mayores fuentes de carga de enfermedad, según la evaluación de los años de vida ajustados por discapacidad. Es común en países de altos ingresos, mientras que la mayoría de las muertes relacionadas con el asma se producen en países de ingresos bajos y medios. Por lo tanto, la creciente prevalencia de EPOC y asma impulsa la demanda de dispositivos de limpieza de mucosidades, como los dispositivos OPEP, lo que refuerza el crecimiento del mercado de dispositivos de presión espiratoria positiva oscilante (OPEP).
Perspectivas basadas en productos
El mercado de dispositivos de presión espiratoria positiva oscilante (OPEP), según el producto, está segmentado en dispositivos PEP con boquilla, dispositivos PEP con mascarilla y dispositivos PEP con botella. El segmento de dispositivos PEP con boquilla tuvo la mayor participación del mercado en 2021. Además, se prevé que registre una CAGR del 5,3% en el mercado durante el período de pronóstico. El PEP con boquilla ayuda a eliminar la mucosidad de los pulmones. También puede prevenir el colapso pulmonar o abrir áreas que se han colapsado. Uno de los factores clave que impulsan el mercado de dispositivos PEP con boquilla es la creciente población de ancianos, junto con tasas más altas de enfermedades crónicas como la enfermedad pulmonar obstructiva crónica (EPOC) y el asma. Según los Centros para el Control y la Prevención de Enfermedades (CDC), aproximadamente 9 millones de personas serán diagnosticadas con bronquitis crónica para 2020, lo que impulsa la necesidad de dispositivos con boquilla.
Información sobre indicaciones
Según las indicaciones, el mercado de dispositivos de presión espiratoria positiva oscilante (OPEP) está segmentado en enfermedad pulmonar obstructiva crónica (EPOC), asma, bronquitis, bronquiectasias, fibrosis quística y otros. El segmento de EPOC tuvo la mayor participación del mercado en 2021. Sin embargo, se prevé que el segmento de asma registre una CAGR del 6,0% durante el período de pronóstico. La EPOC es una enfermedad común y tratable que se caracteriza por la limitación progresiva del flujo de aire y la destrucción de los tejidos. Se asocia con cambios estructurales en los pulmones debido a la inflamación crónica por la exposición prolongada a partículas o gases nocivos, más comúnmente el humo del cigarrillo. La inflamación crónica provoca el estrechamiento de las vías respiratorias y la disminución del retroceso pulmonar.
Los lanzamientos y aprobaciones de productos son estrategias que las empresas suelen adoptar para expandir su presencia global y sus carteras de productos. Además, los actores del mercado de dispositivos de presión espiratoria positiva oscilante (OPEP) se centran en la estrategia de asociación para ampliar su clientela, lo que, a su vez, les permite mantener su marca a nivel mundial. Se prevé que el mercado prospere en los próximos años debido al desarrollo de productos innovadores por parte de los actores del mercado.
Dispositivos de presión espiratoria positiva oscilante
Perspectivas regionales del mercado de dispositivos de presión espiratoria positiva oscilante (OPEP)
Los analistas de Insight Partners explicaron en detalle las tendencias y los factores regionales que influyen en el mercado de dispositivos de presión espiratoria positiva oscilante (OPEP) durante el período de pronóstico. Esta sección también analiza los segmentos y la geografía del mercado de dispositivos de presión espiratoria positiva oscilante (OPEP) en América del Norte, Europa, Asia Pacífico, Medio Oriente y África, y América del Sur y Central.
- Obtenga datos específicos regionales para el mercado de dispositivos de presión espiratoria positiva oscilante (OPEP)
Alcance del informe de mercado sobre dispositivos de presión espiratoria positiva oscilante (OPEP)
| Atributo del informe | Detalles |
|---|---|
| Tamaño del mercado en 2021 | US$ 125,66 millones |
| Tamaño del mercado en 2028 | US$ 179,34 millones |
| CAGR global (2021-2028) | 5,2% |
| Datos históricos | 2019-2020 |
| Período de pronóstico | 2022-2028 |
| Segmentos cubiertos | Por producto
|
| Regiones y países cubiertos | América del norte
|
| Líderes del mercado y perfiles de empresas clave |
|
Densidad de actores del mercado de dispositivos de presión espiratoria positiva oscilante (OPEP): comprensión de su impacto en la dinámica empresarial
El mercado de dispositivos de presión espiratoria positiva oscilante (OPEP) está creciendo rápidamente, impulsado por la creciente demanda de los usuarios finales debido a factores como la evolución de las preferencias de los consumidores, los avances tecnológicos y una mayor conciencia de los beneficios del producto. A medida que aumenta la demanda, las empresas amplían sus ofertas, innovan para satisfacer las necesidades de los consumidores y aprovechan las tendencias emergentes, lo que impulsa aún más el crecimiento del mercado.
La densidad de actores del mercado se refiere a la distribución de las empresas o firmas que operan dentro de un mercado o industria en particular. Indica cuántos competidores (actores del mercado) están presentes en un espacio de mercado determinado en relación con su tamaño o valor total de mercado.
Las principales empresas que operan en el mercado de dispositivos de presión espiratoria positiva oscilante (OPEP) son:
- Compañía farmacéutica Allergan.
- PARI GmbH
- Smiths Medical
- Fisioterapia aérea
- D
Descargo de responsabilidad : Las empresas enumeradas anteriormente no están clasificadas en ningún orden particular.
- Obtenga una descripción general de los principales actores clave del mercado de dispositivos de presión espiratoria positiva oscilante (OPEP)
Perfiles de empresas
- Compañía farmacéutica Allergan.
- PARI GmbH
- Medicina de Smith
- Fisioterapia aérea
- ATENCIÓN MÉDICA D•R BURTON
- Medica Holdings, LLC
- CEGLA Medizintechnik GmbH & Co. KG
- Atención sanitaria competente
- Trudell Medical Internacional
- Mercurio médico
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
COVID-19 was more likely to hospitalize those with moderate-to-severe or uncontrolled asthma. The coronavirus can cause pneumonia, blood clots, and acute respiratory distress syndrome, among other lung issues. The epidemic has added new levels of anxiety for both patients and clinicians for the nearly 37 million Americans who live with a chronic lung illness like asthma or chronic obstructive pulmonary disease. Caring for people with COVID-19 and underlying COPD is very difficult at this time. Certain treatments for COPD patients, such as nebulized bronchodilators and non-invasive ventilation (NIV), are thought to enhance the risk of viral transmission via aerosols. Although oscillating positive expiratory pressure (OPEP) devices have been in use with the increasing cases of COVID-19 in the region as studies shows oscillating positive expiratory pressure (OPEP) devices results in minimizing the effect of respiratory distress due to COVID. Also, the Positive Expiratory Pressure (PEP) flute therapy and Positive End-Expiratory Pressure (PEEP) proved to be led to a small yet statistically significant decrease in the severity of respiratory symptoms in adults with COVID-19 recovering at home as per various research studies.
North America held the largest share of the oscillating positive expiratory pressure (OPEP) devices market and is expected to continue its position over the coming years. These oscillating positive expiratory pressure (OPEP) devices are in high demand in North America's regional segment. Furthermore, the presence of a robust medical infrastructure and the early availability of new products and equipment are aiding the area market's overall development.
Trudell Medical International and Allergan Plc are the top two companies that hold huge market shares in the Oscillating Positive Expiratory Pressure (OPEP) Devices market.
The Oscillating Positive Expiratory Pressure (OPEP) Devices market majorly consists of players such as Allergan Plc.; PARI GmbH; Smiths Medical; AirPhysio; D•R BURTON HEALTHCARE; Medica Holdings, LLC; CEGLA Medizintechnik GmbH & Co. KG; Able Healthcare; Trudell Medical International; Mercury Medical amongst others.
The hospital pharmacies segment dominated the global oscillating positive expiratory pressure (OPEP) devices market and accounted for the largest market share of 60.48% in 2021.
The mouthpiece PEP devices segment held the largest share of the market in the global oscillating positive expiratory pressure (OPEP) devices market and held the largest market share of 94.68% in 2021.
The chronic obstructive pulmonary disease (COPD) segment dominated the global oscillating positive expiratory pressure (OPEP) devices market and accounted for the largest market share of 34.60% in 2021.
Oscillatory positive expiratory pressure (OPEP) devices have been used as a supplement to traditional chest physiotherapy (CPT) to aid in the clearing of respiratory secretions in people who can't cough, especially those with chronic conditions. In chronic airway disorders such as cystic fibrosis, bronchiectasis, bronchitis, bronchial asthma, and primary ciliary dyskinesia syndrome, the usage of OPEP devices is still limited. In chronic obstructive pulmonary disease (COPD), oscillating positive expiratory pressure (OPEP) devices are said to help with sputum clearance.
Key factors that are driving the growth of this market are the growing prevalence of chronic obstructive pulmonary disease (COPD) and asthma, and rising technological advancements are expected to boost the market growth for oscillating positive expiratory pressure (OPEP) devices over the years.
The CAGR value of the oscillating positive expiratory pressure (OPEP) devices market during the forecasted period of 2021–2028 is 5.2%.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Oscillating Positive Expiratory Pressure (OPEP) Devices Market
- Allergan Plc.
- PARI GmbH
- Smiths Medical
- AirPhysio
- D•R BURTON HEALTHCARE
- Medica Holdings, LLC
- CEGLA Medizintechnik GmbH & Co. KG
- Able Healthcare
- Trudell Medical International
- Mercury Medical
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For